MX1 and viral infectious disease: Comprehensive identification of reported blood transcriptional biomarkers of viral infection by systematic review, and their application in standardised SARS-CoV-2 and influenza human challenges with high frequency sampling are major strengths of this study, thus enabling identification of differential temporal profiles of MX1 and IFI27 responses.